UBS recommends a stock-picker approach in Europe’s SMID universe, noting that individual company dynamics will be a larger determinant of outcomes than sweeping macro developments. The bank says the smaller-cap cohort presents varied opportunities, and that firm-level attributes are central to identifying winners.
UBS notes a trade-off in the smaller-cap segment: these companies can be more sensitive to inflation, yet their generally greater domestic focus can provide relative insulation from global market swings. Within that framework, UBS identifies two names as preferred picks based on differentiated business models and resilient earnings profiles.
Inficon
UBS highlights Inficon for its leveraged exposure to the semiconductor equipment cycle, with a particular emphasis on wafer fabrication equipment (WFE) spending connected to AI applications and the push toward advanced nodes. The firm’s market position in precision instrumentation and its focus on niche end markets are cited as reasons it is likely to outpace the wider semiconductor cycle.
According to UBS, Inficon’s leadership in specialty measurement and control tools should help sustain earnings momentum as investment in advanced chip manufacturing continues to accelerate. UBS frames Inficon as a high-quality growth option inside the SMID segment driven by structural demand tailwinds tied to advanced-node capacity expansion.
Elis SA
Elis is presented as a more defensive alternative. UBS points to steady organic growth, reliable pricing power and clear cost visibility as core strengths. The company’s capacity to pass through inflationary pressures is underpinned in the report by its energy hedging strategies and relatively limited exposure to fuel costs.
UBS also flags ongoing deleveraging at Elis as supportive of shareholder returns. Consistent above-trend growth and a low risk of earnings downgrades, in the bank’s view, make Elis a dependable compounder within the SMID space even amid broader economic uncertainty.
In sum, UBS’s guidance emphasizes picking companies with identifiable, durable advantages - such as niche market leadership or defensible pricing - rather than relying on macro direction alone. The bank’s preferred names illustrate two contrasting routes to attractive SMID outcomes: cyclical growth with structural support at Inficon and defensive compound growth with strong pass-through at Elis.